Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial
Chen, Shasha, Shen, Weina, Liu, Yuhuan, Dong, Qiang, Shi, Yongquan
Published in Chinese medical journal (20.07.2023)
Published in Chinese medical journal (20.07.2023)
Get full text
Journal Article
Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor
Ji, Dongmei, Jiang, Shiyu, Zhang, Qunling, Wang, Y. Ken, Zhang, Jian, Shen, Weina, Li, Wenhua, Liu, Rujiao, Wang, Jessica, Mavis, Cory, Gu, Juan J., Hu, Xichun
Published in Clinical and translational science (01.08.2023)
Published in Clinical and translational science (01.08.2023)
Get full text
Journal Article
Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation
Kuang, Muyu, Zhou, Zhenhua, Lu, Zhongyuan, Shen, Weina, Ge, Haiyan, Tao, Xiaoting, Zhao, Yue, Zhuge, Lingdun, Sun, Yihua, Ji, Dongmei, Zhang, Huibiao
Published in The clinical respiratory journal (01.03.2023)
Published in The clinical respiratory journal (01.03.2023)
Get full text
Journal Article
A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers
Zhang, Jian, Yang, Nong, Ji, Dongmei, Shen, Weina, Li, Wenhua, Han, Rubing, Wang, Ning, Tao, Haoxun, Chapman, Sonya C., Sykes, Amanda K., Zhang, Wanli, Hu, Xichun
Published in Targeted oncology (01.03.2021)
Published in Targeted oncology (01.03.2021)
Get full text
Journal Article
Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases
Li, Xiaoyang, Shen, Weina, Cao, Junning, Wang, Jianmin, Chen, Fangyuan, Wang, Chun, Zou, Shanhua, Shen, Boyong, Zhao, Ren, Li, Junmin, Shen, Zhixiang
Published in Annals of hematology (01.11.2012)
Published in Annals of hematology (01.11.2012)
Get full text
Journal Article
Phase I Trial of a Novel Anti-HER2 Antibody-drug Conjugate, ARX788, for the Treatment of HER2-positive Metastatic Breast Cancer
Zhang, Jian, Ji, Dongmei, Shen, Weina, Xiao, Qin, Gu, Yajia, O'Shaughnessy, Joyce, Hu, Xichun
Published in Clinical cancer research (03.10.2022)
Published in Clinical cancer research (03.10.2022)
Get full text
Journal Article
Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study
Ji, Dongmei, Shen, Weina, Li, Ting, Wang, Huan, Bai, Jianling, Cao, Junning, Hu, Xichun
Published in Investigational new drugs (01.08.2024)
Published in Investigational new drugs (01.08.2024)
Get full text
Journal Article
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I Study
Zhang, Jian, Ji, Dongmei, Cai, Li, Yao, Herui, Yan, Min, Wang, Xiaojia, Shen, Weina, Du, Yiqun, Pang, Hui, Lai, Xiuping, Zeng, Huiai, Huang, Jian, Sun, Yan, Peng, Xinxin, Xu, Junfang, Yang, Jing, Yang, Fei, Xu, Ting, Hu, Xichun
Published in Clinical cancer research (15.02.2022)
Published in Clinical cancer research (15.02.2022)
Get full text
Journal Article
Abstract 3919: GSK458, a novel oral dual PI3K/mTOR Inhibitor, is effective in preclinical model of T-cell lymphoma alone and in combination therapies
Gu, Juan J., yang, Lianjuan, He, Jing, Shen, Weina, Mavis, Cory, Hernandez-Ilizaliturri, Francisco
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors: A Phase I Trial
Cao, Junning, Guo, Hongqian, Ji, Dongmei, Shen, Weina, Zhang, Shun, Hsieh, Chih-Yi, Xiong Cai, Sui, Edward Tian, Ye, Xu, Cong, Zhang, Pin, Xu, Binghe
Published in The oncologist (Dayton, Ohio) (11.12.2023)
Published in The oncologist (Dayton, Ohio) (11.12.2023)
Get full text
Journal Article
A multicenter, single-arm phase 2 study of surufatinib plus toripalimab for patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer
Ji, Dongmei, Song, Lijie, Cheng, Ying, Shen, Weina, Kuang, Muyu, Chen, Jiaying, Yang, Minjie, Cui, Hongxia, Zhou, Jinghong, Shi, Haiyan, Tan, Panfeng, Fan, Songhua, Shi, Michael, Su, Weiguo, Ji, Qinghai
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
Zhang, Panpan, Shi, Si, Xu, Jianming, Chen, Zhendong, Song, Lijie, Zhang, Xing, Cheng, Ying, Zhang, Yanqiao, Ye, Feng, Li, Zhiping, Yin, Fei, Ji, Dongmei, Gao, Heli, Li, Yi, Chen, Wei, Yang, Minjie, Weng, Desheng, Wu, Chunjiao, Ma, Yue, Sheng, Wang, Zhao, Yaqin, Yin, Xiaolei, Shen, Weina, Su, Weiguo, Shi, Michael, Fan, Songhua, Tan, Panfeng, Xu, Qian, Lu, Ming, Shen, Lin
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas
Cao, Junning, Li, Zhiming, Zhou, Jianfeng, Ji, Dongmei, Shen, Weina, Sun, Peng, Wang, Yu, Li, Dengju, Hong, Zhenya, Wang, Gaoxiang, Duan, Xianlin, Yu, Chen, Cai, Yu, Su, Weiguo
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Abstract PD8-04: Safety and anti-tumor activity of ARX788 in HER2-positive metastatic breast cancer patients whose disease is resistant/refractory to HER2 targeted agents (trastuzumab, ADCs, TKIs, and bispecific antibodies): ACE-Breast-01 trial results
Zhang, Jiang, Ji, Dongmei, Shen, Weina, Xiao, Qin, Gu, Yajia, O’Shaughnessy, Joyce, Xia, Gang, Ji, Yanping, Xiong, Gaozhun, Li, Matt, Xu, Dong, Cartmell, Robert, Song, Cynthia, Yan, Jinchun, Hu, Xichun
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract P2-13-10: First-in-human HER2-targeted bispecific antibody KN026 for the treatment of patients with HER2-positive metastatic breast cancer: Results from a phase I study
Zhang, Jian, Ji, Dongmei, Cai, Li, Yao, Herui, Yan, Min, Wang, Xiaojia, Shen, Weina, Du, Yiqun, Pang, Hui, Lai, Xiuping, Zeng, Huiai, Huang, Jian, Sun, Yan, Peng, Xinxin, Xu, Junfang, Yang, Jing, Yang, Fei, Xu, Ting, Hu, Xichun
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract CT164: A phase 1 study of abemaciclib in Chinese patients with advanced and/or metastatic cancers
Hu, Xichun, Yang, Nong, Zhang, Jian, Zhou, Chunhua, Ji, Dongmei, Shen, Weina, Li, Wenhua, Han, Rubing, Lu, Yi, Chapman, Sonya C.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Preliminary safety, efficacy and pharmacokinetics (PK) results of KN026, a HER2 bispecific antibody in patients (pts) with HER2-positive metastatic breast cancer
Ji, Dongmei, Zhang, Jian, Shen, Weina, Du, Yiqun, Xu, June, Yang, Jing, Luo, Xin, Kong, Paul, Yang, Fei, Hu, Xi-Chun
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
GSK458 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in T Cell Lymphomas As a Single Agent and in Combination Therapy
Gu, Juan, Yang, Lianjuan, Gaughan, Dennis C, He, Ling, Shen, Weina, Mavis, Cory, Hernandez-Ilizaliturri, Francisco J.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article